🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
FDA approves Lupin's new generic

Pharma Major Lupin announced that its US subsidiary, Gavis Pharmaceuticals LLC., (collectively Lupin) has received final...

June 23, 2016 | Thursday | News
Gout therapeutics market clocks $988.7 mn in 2011

Singapore: GlobalData's analysis shows that the global gout therapeutics market grew at a compound annual growth rate (...

May 23, 2012 | Wednesday | Analysis
Pfizer, Repligen to push spinal muscular atrophy program

Singapore: US-based Repligen has entered into an exclusive worldwide licensing agreement with Pfizer to advance Repligen...

January 7, 2013 | Monday | News
UK commits $1.6 bn to fight AIDS, TB, Malaria

Singapore: United Kingdom (UK) has committed to contrbute $1.6 billion to fight AIDS, Tuberculosis and Malaria. Ms Just...

September 24, 2013 | Tuesday | News
China firm Beigene raises $75 mn

Singapore: China based biotech firm developing targeted and immune-oncology therapeutics, BeiGene, has raised $75 millio...

November 18, 2014 | Tuesday | News
Johns Hopkins releases NCD policy briefs

Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterpris...

February 5, 2013 | Tuesday | Analysis
Suven gets patents for NCE in Canada, China and India

Bangalore: Suven Life Sciences received three product patents one each from Canada (2600271), China (CN 101544592B) and ...

February 4, 2014 | Tuesday | News
Gilead's cancer drug under FDA scrutiny

Singapore: US Food and Drug Administration has raised alarm for Gilead Science's cancer medicine Zydelig (idelalisib) du...

March 15, 2016 | Tuesday | Regulatory
CytRx gets FDA nod Aldoxorubicin cancer trial

Singapore: US-based CytRx, a biopharmaceutical R&D company specializing in oncology, reached an agreement with the U...

May 10, 2013 | Friday | Regulatory
China's Zai Lab raises $100mn

Singapore: China based Zai Lab, an innovative biopharmaceutical company, has secured over $100 million in Series B finan...

January 11, 2016 | Monday | News
CSL files marketing plea for Privigen in Europe

Singapore: Australian company CSL Behring has submitted a variation application to the European Medicines Agency (EMA) f...

June 1, 2012 | Friday | Regulatory
Orient, NanoCarrier sign deal for Nanoplatin trial

Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreeme...

November 29, 2012 | Thursday | News
Novogen's ovarian cancer drug set for trials in H1 2016

US-Australian drug discovery company, Novogen Limited has provided an update on progress regarding the development of Ca...

May 3, 2016 | Tuesday | News
Japanese scientist inch closer to Toxoplasma vaccine discovery

Tokyo: Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunod...

November 4, 2015 | Wednesday | News
Australia's Gordagen forays into Japan with Matsumoto's support

Tokyo: Gordagen Pharmaceuticals, an Australian company developing evidence-based nutraceuticals and pharmaceuticals, has...

January 6, 2016 | Wednesday | News
Takeda gets NDA approval for VAXEM Hib vaccine in Japan

Takeda Pharmaceutical Company Limited has announced that the Japanese Ministry of Health, Labour and Welfare has approve...

February 1, 2016 | Monday | News
Aspirin use increases risk of age-related eye disease

Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WM...

January 23, 2013 | Wednesday | News
Systems Toxicology Computational Challenge explores toxicant prediction

Singapore: The Systems Toxicology Computational Challenge run under the sbv IMPROVER umbrella, a crowdsourcing initiativ...

July 20, 2016 | Wednesday | News